Calibration of CTS5 in Women With Early Estrogen Receptor-Positive Breast Cancer

J Clin Oncol. 2021 Feb 1;39(4):338-339. doi: 10.1200/JCO.20.02551. Epub 2020 Dec 16.

Authors

Mitch Dowsett¹, Ivana Sestak¹, Jack Cuzick¹

Affiliation

¹ Mitch Dowsett, PhD, Ralph Lauren Centre for Breast Cancer Research, Royal Marden Hospital, London, UK and Ivana Sestak, PhD and Jack Cuzick, PhD, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.

PMID: 33326252
DOI: 10.1200/JCO.20.02551

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents, Hormonal / therapeutic use
Breast Neoplasms* / drug therapy
Calibration
Female
Humans
Prognosis
Receptors, Estrogen*

Substances

Antineoplastic Agents, Hormonal
Receptors, Estrogen

Grants and funding